S0629, OBSERVATION OR COMBINATION CHEMOTHERAPY, BORTEZOMIB, THALIDOMIDE, AND RITUXIMAB FOLLOWED BY TWO AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTS IN TREATING PATIENTS WITH WALDENSTROM MACROGLOBULINEMIA: